- 1D
- 3D
- 1W
- 1M
- 6M
- 1Y
- 3Y
- 5Y
Announcements
- FDA Grants Orphan Drug Designation
- Notice of Annual General Meeting
- Positive EMA Opinion on Orphan Drug Designation
- Annual Report 2024 published
- Financial Statement 1 January to 31 December 2024
- Notice of Financial Statement and Annual Report
- Holding(s) in Company
- Change of Broker
- Results of Oversubscribed Placing
More ▼
Key statistics
On Friday, Faron Pharmaceuticals Oy (FARN:LSE) closed at 167.50, 14.73% above the 52 week low of 146.00 set on Feb 06, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 162.50 |
|---|---|
| High | 189.00 |
| Low | 167.50 |
| Bid | 160.00 |
| Offer | 195.00 |
| Previous close | 162.50 |
| Average volume | 6.15k |
|---|---|
| Shares outstanding | 115.78m |
| Free float | 82.89m |
| P/E (TTM) | -- |
| Market cap | 188.15m GBP |
| EPS (TTM) | -0.2522 GBP |
Data delayed at least 20 minutes, as of Feb 06 2026 15:56 GMT.
More ▼
